(267 days)
No
The device description and performance studies focus on the mechanical properties, biocompatibility, and compatibility of the physical components (titanium base, ceramic mesostructure, screw, cement) for dental implant abutments. There is no mention of any software, algorithms, or data processing that would suggest the use of AI or ML.
No
The device is a prosthetic component for dental implants, described as an "aid in prosthetic rehabilitation for the purpose of providing a suitable chewing function," which replaces lost function rather than treating a disease or condition.
No.
The device is a prosthetic component intended for use in dental implant procedures to support restorations and aid in chewing function, not to diagnose medical conditions or diseases.
No
The device description clearly outlines physical components made of titanium and ceramic, as well as cement, which are all hardware. There is no mention of software as a component of this device.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the device is for supporting dental restorations in the mouth (mandibles and maxillae). This is a direct clinical application within the body.
- Device Description: The description details a prefabricated prosthetic component for dental implants, made of titanium and ceramic, designed to be attached to an implant body and support a crown. This is a physical device used in a surgical/restorative procedure.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or screening.
The device is a dental prosthetic component, not a diagnostic tool used outside the body on biological samples.
N/A
Intended Use / Indications for Use
IPS e.max® Press Abutment Solutions for Viteo Base Ti is intended for use in partially or fully edentulous mandibles and maxillae in support of single or multi-unit cement retained restorations.
IPS e.max Press Abutment Solutions is recommended for the fabrication of:
- Hybrid abutments for single-tooth restorations -
- Hybrid abutment crowns for restorations -
IPS e.max Press Abutment Solutions for Viteo Base-Ti are compatible with the following Implant Systems
| Implant brand and type | Clearance ID | Platform and Implant Diameter(s) | |
|---|---|---|---|
| Straumann® Dental Implant System, | Bone Level® | ||
| K150938 | |||
| K130222 | NC: 3.3 mm | RC: 4.1, 4.8 mm | |
| Nobel Biocare®, | NobelActive® | ||
| K071370 | |||
| K041661 | NP: 3.5 mm | RP: 4.3, 5.0 mm | |
| Biomet 3i® | Osseotite® | ||
| Certain® | |||
| K111216 | BI-OC: 3.4 mm | BI-OC: 4.1, 5.0 mm | |
| Astra Tech AB | OsseoSpeed® | ||
| K101732 | |||
| K091239 | OS: 3.5, 4.0 mm | OS: 4.5, 5.0 mm |
Product codes (comma separated list FDA assigned to the subject device)
NHA
Device Description
IPS e.max Press Abutment Solutions for Viteo Base Ti is a prefabricated prosthetic component for endosseous dental implants to support prosthetic restorations in partially or fully edentulous jaws. The Viteo Base-Ti is the apical component of a two-piece abutment. A separate mesostructure fabricated out of IPS e.max Press ceramic is attached to the Viteo Base-Ti extraorally using Multilink Hybrid Abutment Cement (K130436). This part then serves as an intermediary to facilitate the connection of the 2-part abutment to the prosthetic material (crown). The abutment as a whole is intended to be used as an aid in prosthetic rehabilitation for the purpose of providing a suitable chewing function. A compatible screw is included with the Viteo Base-Ti for attachment of the completed hybrid abutment to the implant body. Alternatively, the mesostructure may be fabricated into the prosthetic restoration and attached to the Viteo Base-Ti via the screw to form a hybrid crown/abutment, thereby incorporating the top half of the two-piece abutment into the body of the crown.
The Viteo Base Ti is made of Ti-6Al-4V ELI Titanium Grade 23 and is provided with a compatible screw made of the same materials. Viteo Base-Ti is available in two platform sizes (SD and MD) for various cleared implant systems as described in this summary. The upper part (pillar) of the Viteo Base Ti can be shortened individually, has a blasted surface to support bonding of the restorative part, and has an internal retentive lock to circumvent rotation. The IPS e.max Press Abutment Solutions for Viteo Base Ti are parts of the implant system which consists of:
- Implant Body – marketed by the Implant Manufacturer
- Viteo Base Ti - Titanium part Included in subject device
- Screw - Titanium screw Included in subject device
- IPS e.max Press either as a part of the abutment or a Hybrid Abutment crown included in the subject device.
- -Multilink Hybrid Abutment Cement – to bond together the Viteo Base Ti abutment part and the IPS e.max Press ceramic part included in the subject device.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
partially or fully edentulous mandibles and maxillae
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The following performance testing was submitted in this 510K application to support substantial equivalence:
- Worst case dynamic fatigue testing according to ISO 14801: Dynamic Fatigue Testing, considering the FDA Guidance Class II Special Controls for Root form Endosseous Dental Implants and Endosseous Dental Abutments. Fatigue results shown in previously cleared titanium bases for the predicate device did not substantially differ from the test results shown for Viteo Base Ti.
- Sterilization validation according to ISO 17665-1, ISO/TR 17665-2 and ANSI/AAMI ST79.
- Compatibility of the Viteo Base Ti interface to the implant bodies listed above was verified by measuring Data & tolerance analysis which demonstrated that the Viteo Base-Ti dimensional specifications are compatible with the appropriate implant system.
Biocompatibility:
The subject device was evaluated for Biocompatibility according to ISO 10993-1 and ISO 7405. The material was tested for corrosion according to ISO 10271:2011 and EN ISO 22674:2006 and met the requirements for those standards for total ion release and electrochemical test. The chemical composition is according to ASTM F136-08. The blasted surface is not exposed to the oral environment as the mesostructured or hybrid crown is luted with self-curing cement to the blasted surface extraorally. Therefore, additional biocompatibility testing of the Viteo Base-Ti with blasted surface was not conducted based on risk assessment. The fabricated articles are subject to a cleaning procedure. A documented cleaning validation proves that the surface is free from any remaining contaminant after the surface blasting procedure. Before inserting the fabricated abutment into the patient's mouth, a steam sterilization is recommended in the instructions for use. This does not alter the surface and provides a final cleaning step. The material was also evaluated for hypersensitivity/sensitization, irritation, acute and subchronic systemic toxicity - oral/inhalation, genotoxicity and Implantation with passing results.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.3630 Endosseous dental implant abutment.
(a)
Identification. An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of a caduceus, which is a symbol often associated with healthcare and medicine.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
December 15, 2016
Ivoclar Vivadent AG % Donna Hartnett Director OA/Regulatory Affairs Ivoclar Vivadent, Inc. 175 Pineview Drive Amherst, New York 14228
Re: K160798
Trade/Device Name: IPS e.max® Press Abutment Solutions for Viteo Base Ti Regulation Number: 21 CFR 872.3630 Regulation Name: Endosseous Dental Implant Abutment Regulatory Class: Class II Product Code: NHA Dated: November 4, 2016 Received: November 14, 2016
Dear Donna Hartnett:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in
1
the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Michael J. Ryan -S
for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
510(k) Number (if known): : K160798
Device Name: IPS e.max® Press Abutment Solutions for Viteo Base Ti
Indications For Use:
IPS e.max Press Abutment Solutions for Viteo Base Ti is intended for use in partially or fully edentulous mandibles and maxillae in support of single or multi-unit cement retained restorations.
IPS e.max Press Abutment Solutions is recommended for the fabrication of:
- Hybrid abutments for single-tooth restorations -
- Hybrid abutment crowns for restorations -
IPS e.max Press Abutment Solutions for Viteo Base-Ti are compatible with the following Implant Systems
| Implant brand and type | Clearance ID | Platform and Implant Diameter(s) | |
|---|---|---|---|
| Straumann® Dental Implant System, | Bone Level® | ||
| K150938 | |||
| K130222 | NC: 3.3 mm | RC: 4.1, 4.8 mm | |
| Nobel Biocare®, | NobelActive® | ||
| K071370 | |||
| K041661 | NP: 3.5 mm | RP: 4.3, 5.0 mm | |
| Biomet 3i® | Osseotite® | ||
| Certain® | |||
| K111216 | BI-OC: 3.4 mm | BI-OC: 4.1, 5.0 mm | |
| Astra Tech AB | OsseoSpeed® | ||
| K101732 | |||
| K091239 | OS: 3.5, 4.0 mm | OS: 4.5, 5.0 mm |
Prescription Use X AND/OR (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
3
IPS e.max Press Abutment Solutions for Viteo Base - Ti
| Contact: | Donna Marie Hartnett |
|---|---|
| Company: | Ivoclar Vivadent, AG |
| Bendererstrasse 2, FL-9494 | |
| Schaan, Liechtenstein | |
| +423-235-3535 | |
| Date Prepared: | December 14, 2016 |
| Proprietary Name: | IPS e.max® Press Abutment Solutions for Viteo Base Ti |
| Classification Name: | Endosseous Dental Implant Abutment (872.3630) |
| (Classification Code NHA) |
IPS e.max Press Abutment Solutions for Viteo Base Ti is a Device Description: prefabricated prosthetic component for endosseous dental implants to support prosthetic restorations in partially or fully edentulous jaws. The Viteo Base-Ti is the apical component of a two-piece abutment. A separate mesostructure fabricated out of IPS e.max Press ceramic is attached to the Viteo Base-Ti extraorally using Multilink Hybrid Abutment Cement (K130436). This part then serves as an intermediary to facilitate the connection of the 2-part abutment to the prosthetic material (crown). The abutment as a whole is intended to be used as an aid in prosthetic rehabilitation for the purpose of providing a suitable chewing function. A compatible screw is included with the Viteo Base-Ti for attachment of the completed hybrid abutment to the implant body. Alternatively, the mesostructure may be fabricated into the prosthetic restoration and attached to the Viteo Base-Ti via the screw to form a hybrid crown/abutment, thereby incorporating the top half of the two-piece abutment into the body of the crown.
4
IPS e.max Press Abutment Solutions for Viteo Base - Ti
The Viteo Base Ti is made of Ti-6Al-4V ELI Titanium Grade 23 and is provided with a compatible screw made of the same materials. Viteo Base-Ti is available in two platform sizes (SD and MD) for various cleared implant systems as described in this summary. The upper part (pillar) of the Viteo Base Ti can be shortened individually, has a blasted surface to support bonding of the restorative part, and has an internal retentive lock to circumvent rotation. The IPS e.max Press Abutment Solutions for Viteo Base Ti are parts of the implant system which consists of:
- । Implant Body – marketed by the Implant Manufacturer
- । Viteo Base Ti - Titanium part Included in subject device
- । Screw - Titanium screw Included in subject device
- IPS e.max Press either as a part of the abutment or a Hybrid । Abutment crown included in the subject device.
- -Multilink Hybrid Abutment Cement – to bond together the Viteo Base Ti abutment part and the IPS e.max Press ceramic part included in the subject device.
Primary Predicate Device: Reference predicate device: IPS e.max Press Abutment Solutions (K120053) IPS e.max Press Abutment Solutions for Nobel Biocare (K124008)
5
IPS e.max Press Abutment Solutions for Viteo Base - Ti
Indications for Use
IPS e.max Press Abutment Solutions for Viteo Base Ti is intended for use in partially or fully edentulous mandibles and maxillae in support of single or multi-unit cement retained restorations.
IPS e.max Press Abutment Solutions is recommended for the fabrication of:
- -Hybrid abutments for single-tooth restorations
- Hybrid abutment crowns for restorations -
IPS e.max Press Abutment Solutions for Viteo Base-Ti are compatible with the following Implant Systems
| Implant brand and type | Clearance ID | Platform | Implant Diameter(s) |
|---|---|---|---|
| Straumann® Dental Implant | |||
| System, | Bone Level® | ||
| K150938 | |||
| K130222 | NC: | 4.1, 4.8 m | |
| 3.3 mm | |||
| RC: | |||
| Nobel Biocare®, | NobelActive® | ||
| K071370 | |||
| K041661 | NP: | 4.3, 5.0 m | |
| 3.5 mm | |||
| RP: | |||
| Biomet 3i® | Osseotite® | ||
| Certain® | |||
| K111216 | BI-OC: | 4.1, 5.0 m | |
| 3.4 mm | |||
| BI-OC: | |||
| Astra Tech AB | OsseoSpeed® | ||
| K101732 | |||
| K091239 | OS: | 4.5, 5.0 m | |
| 3.5, 4.0 mm | |||
| OS: |
6
IPS e.max Press Abutment Solutions for Viteo Base Ti
Comparison to predicate device:
| Comparison Matrix (Table 1) | Subject Device | (C.) Predicate Device(s) (primary and reference) | ||
|---|---|---|---|---|
| Name of | Company | Ivoclar Vivadent AG | Ivoclar Vivadent AG | Ivoclar Vivadent AG |
| Device | IPS e.max Press Abutment Solutions for | |||
| Viteo Base Ti | IPS e.max Press Abutment Solutions for | |||
| Straumann Cementable abutment | IPS e.max PRESS Abutment Solutions for | |||
| Nobel Biocare | ||||
| 510(k) number | K160798 | K120053 (Primary) | K124008 (Reference) | |
| Classification & Product Code | 872.3630 - NHA | 872.3630 - NHA | 872.3630 - NHA | |
| (D.) Intended use | ||||
| Indications for use | IPS e.max Press Abutment Solutions for | |||
| Viteo Base Ti is intended for use in | ||||
| partially or fully edentulous mandibles | ||||
| and maxillae in support of single or multi- | ||||
| unit cement retained restorations. | ||||
| IPS e.max Press Abutment Solutions is | ||||
| recommended for the fabrication of: |
- Hybrid abutments for single-tooth restorations
- Hybrid abutment crowns for restorations | IPS e.max® Press Abutment Solutions is intended
for use in partially or fully endentuous mandibles and
maxillae in support of single or multiple-unit cement
retained restorations.
IPS e.max Press Abutment Solutions is
recommended for the fabrication of: - Hybrid abutments for single-tooth restorations
- Hybrid abutment crowns for restorations | IPS e.max Press Abutment Solutions for Nobel
Biocare is intended for use in partially or fully
endentuous mandibles and maxillae in support of
single or multiple-unit cement retained restorations.
IPS e.max Press Abutment Solutions for Nobel
Biocare is recommended for the fabrication of: - Hybrid abutments for single-tooth restorations
- Hybrid abutment crowns for restorations |
7
IPS e.max Press Abutment Solutions for Viteo Base Ti
| I) Comparison Matrix (Table 1) | Subject Device | (C.) Predicate Device(s) (primary and reference) | |||
|---|---|---|---|---|---|
| Company Name of Device | Ivoclar Vivadent AG | ||||
| IPS e.max Press Abutment Solutions for Viteo Base Ti | Ivoclar Vivadent AG | ||||
| IPS e.max Press Abutment Solutions for Straumann Cementable abutment | Ivoclar Vivadent AG | ||||
| IPS e.max PRESS Abutment Solutions for Nobel Biocare | |||||
| Compatible Abutment /Implant Systems | IPS e.max Press Abutment Solutions are compatible for use with the following implant systems: |
- Nobel Biocare® NobelActive®
- Biomet 3i® Osseotite® Certain®
- Straumann® Bone Level®
- Astra Tech OsseoSpeed® | The following Ti bases and implant bodies are intended to be used with IPS emax Press Abutment Solutions
- Straumann RC Cementable abutment D 5.0-6.5mm, GH 1-0-3.0mm, HTi 4.0-5.5mm
- Straumann Bone Level RC Implant Ø4.1 or Ø4.8 | The following Ti bases and implant bodies are intended to be used with IPS e.max Press Abutment Solutions for Nobel Biocare:
- Nobel Snappy Abutment 4.0 internal tni-channel NP, RP, WP, 6.0
- NobelReplace Tapered Implant NP Ø3.5, RP Ø4.3, WP Ø5.0, Ø6.0
- Replace Select Tapered Implant NP Ø3.5, RP Ø4.3, WP Ø5.0, Ø6.0 |
| (E.) Technological Characteristics | | | | | |
| pre-fabricated part(s) | Design attributes | Raw material Abutment | Ti-6Al-4V ELI | Ti-6Al-7Nb | Ti-6Al-4V |
| | | Angulation (implant vs. abutment axis) | straight i.e. 0° | straight i.e. 0° | straight i.e. 0° |
| | | Collar-diameter | 4.5 – 5.2 mm | 5.0 – 6.5 mm | 4.5 , 5.5, 6.5mm |
| | | Height above collar | Nominal 6.0 mm; may shorten to 4.0mm | 4.0 – 5.5 mm | 7.0 mm |
| | | Engaging / Non-Engaging | Engaging | Engaging | Engaging |
| | | Fixation | Abutment Screw | Abutment Screw | Abutment Screw |
| | | Bonding Surface | Blasted 50µm | n.s. | n.s. |
| | | Raw material Screw | Ti-6Al-4V ELI | Ti-6Al-7Nb | Ti-6Al-4V |
8
IPS e.max Press Abutment Solutions for Viteo Base Ti
| I) Comparison Matrix (Table 1) | Subject Device | (C.) Predicate Device(s) (primary and reference) | ||
|---|---|---|---|---|
| Name of | ||||
| Company | Ivoclar Vivadent AG | Ivoclar Vivadent AG | Ivoclar Vivadent AG | |
| Device | IPS e.max Press Abutment Solutions for | |||
| Viteo Base Ti | IPS e.max Press Abutment Solutions for | |||
| Straumann Cementable abutment | IPS e.max PRESS Abutment Solutions for | |||
| Nobel Biocare | ||||
| Illustration of | ||||
| pre-fabricated part | Image: Abutment for Viteo Base Ti | Image: Abutment for Straumann Cementable abutment | Image: Abutment for Nobel Biocare | |
| Comparison Matrix (Table 1) | Subject Device | (C.) Predicate Device(s) (primary and reference) | ||
| Name of | ||||
| Company | ||||
| Device | Ivoclar Vivadent AG | Ivoclar Vivadent AG | Ivoclar Vivadent AG | |
| IPS e.max Press Abutment Solutions for | ||||
| Viteo Base Ti | IPS e.max Press Abutment Solutions for | |||
| Straumann Cementable abutment | IPS e.max PRESS Abutment Solutions for | |||
| Nobel Biocare | ||||
| restorative part | ||||
| (abutment crown) | Material(s) for Abutment | |||
| Crown | Ceramic Ingots | |||
| (i.e. IPS e.max® press family) | Ceramic Ingots | |||
| (i.e. IPS e.max® press family) | Ceramic Ingots | |||
| (i.e. IPS e.max® press family) | ||||
| Retaining of Crown | By cementation | By cementation | By cementation | |
| Max. angulation | ||||
| (implant- vs. crown | ||||
| axis) | Angular correction allowed between | |||
| 0°-20° | Angular correction allowed between | |||
| 0°-20° | Angular correction allowed between | |||
| 0°-20° | ||||
| Final Height | Set by Dental technician | Set by Dental technician | Set by Dental technician | |
| Process | ||||
| constraints | Applicable technique(s) | |||
| for Abutment Crown | Press techniques | Press technique | Press technique | |
| Intended Design | ||||
| Workflows | wax-up | wax-up | wax-up | |
| /workflows | Manufacturing Workflow | traditional | traditional | traditional |
| (F.) Performance Data (pre-fabricated part) | ||||
| Mechanical | ||||
| Fatigue | Worst case evaluation was done for each implant type | |||
| listed in Table 1. The dynamic fatigue test for | ||||
| endosseous implants acc. ISO 14801 demonstrated | ||||
| that the tested implants systems containing the | ||||
| corresponding Viteo-Abutment run-out successfully. | The dynamic fatigue test for endosseous implants | |||
| acc. ISO 14801 demonstrated that the tested | ||||
| Straumann implant system run-out successfully. | The dynamic fatigue test for endosseous implants | |||
| acc. ISO 14801 demonstrated that the tested Nobel | ||||
| implant system run-out successfully. | ||||
| Microbial | Sterile | Not delivered sterile | Not delivered sterile | Not delivered sterile |
| Re-useable | Single use only | Single use only | Single use only |
9
IPS e.max Press Abutment Solutions for Viteo Base Ti
10
IPS e.max Press Abutment Solutions for Viteo Base Ti
Testing Summary:
The following performance testing was submitted in this 510K application to support substantial equivalence:
- . Worst case dynamic fatigue testing according to ISO 14801: Dynamic Fatigue Testing, considering the FDA Guidance Class II Special Controls for Root form Endosseous Dental Implants and Endosseous Dental Abutments. Fatigue results shown in previously cleared titanium bases for the predicate device did not substantially differ from the test results shown for Viteo Base Ti.
- Sterilization validation according to ISO 17665-1, ISO/TR 17665-2 and ANSI/AAMI ST79 .
- Compatibility of the Viteo Base Ti interface to the implant bodies listed above was . verified by measuring Data & tolerance analysis which demonstrated that the Viteo Base-Ti dimensional specifications are compatible with the appropriate implant system.
Biocompatibility:
The subject device was evaluated for Biocompatibility according to ISO 10993-1 and ISO 7405. The material was tested for corrosion according to ISO 10271:2011 and EN ISO 22674:2006 and met the requirements for those standards for total ion release and electrochemical test. The chemical composition is according to ASTM F136-08. The blasted surface is not exposed to the oral environment as the mesostructured or hybrid crown is luted with self-curing cement to the blasted surface extraorally. Therefore, additional biocompatibility testing of the Viteo Base-Ti with blasted surface was not conducted based on risk assessment. The fabricated articles are subject to a cleaning procedure. A documented cleaning validation proves that the surface is free from any remaining contaminant after the surface blasting procedure. Before inserting the fabricated abutment into the patient's mouth, a steam sterilization is recommended in the instructions for use. This does not alter the surface and provides a final cleaning step. The material was also evaluated for hypersensitivity/sensitization, irritation, acute and subchronic systemic toxicity - oral/inhalation, genotoxicity and Implantation with passing results.
Conclusion: The documentation submitted in this premarket notification demonstrates that the IPS e.max Press Abutment Solutions for Viteo Base Ti are substantially equivalent to the primary predicate IPS e.max Press Abutment Solutions (K120053).